Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Small Cell Lung Carcinoma × Afatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Etoposide 5 Radiotherapy 3 Docetaxel 2 Cisplatin 2 venetoclax 1 trametinib 1 tislelizumab 1 talazoparib 1 rovalpituzumab tesirine 1 regorafenib 1 olaparib 1 obatoclax 1 fludarabine phosphate 1 etoposide phosphate 1 enoxaparin sodium 1 durvalumab 1 alpha-Tocopherol 1 Vitamin E 1 Topotecan 1 Tomography, Optical Coherence 1 Thymalfasin 1 Taxes 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Paclitaxel 1 Microarray Analysis 1 Magnetic Resonance Spectroscopy 1 Isotretinoin 1 Irinotecan 1 Immunologic Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02876081 2017-09-11

THEN

Fondation Hôpital Saint-Joseph

Phase 2 Withdrawn

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡